CLINICAL TRIALS PROFILE FOR DULOXETINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for duloxetine hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00036309 ↗ | Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder | Completed | Eli Lilly and Company | Phase 3 | 2002-05-01 | The purpose of this study is to determine if duloxetine is effective when compared to placebo in preventing recurrence of major depressive disorder in patients who have responded to open-label duloxetine treatment. |
| NCT00036335 ↗ | Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain | Completed | Eli Lilly and Company | Phase 3 | 2002-03-01 | The purposes of this study are to determine whether an investigational drug can help patients suffering from major depression with pain symptoms, and gather data on the safety of the investigational drug including any side effects that might be associated with it. |
| NCT00042562 ↗ | Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression | Completed | Eli Lilly and Company | Phase 3 | 2002-12-01 | The purposes of this study are to determine: The safety of duloxetine and any side effects that might be associated with it. Whether duloxetine can help patients with major depression. The safety associated with switching from a medication you may be taking for depression to taking duloxetine. It is possible that information collected during this study will be analyzed by the sponsor in the future to evaluate duloxetine for other possible uses or for other medical or scientific purposes other than those currently proposed. |
| NCT00042575 ↗ | Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression | Completed | Eli Lilly and Company | Phase 3 | 2002-06-01 | The Purposes of this Study are to determine: The safety of duloxetine and any side effects that might be associated with it. Whether duloxetine can help patients with major depression. It is possible that information collected during this study will be analyzed by the sponsor in the future to evaluate duloxetine for other possible uses or for other medical or scientific purposes other than those currently proposed. Duloxetine might not have any good effects for you. |
| NCT00058968 ↗ | A Study for the Treatment of Painful Diabetic Neuropathy | Completed | Eli Lilly and Company | Phase 3 | 2002-10-01 | The purpose of the study is to determine if duloxetine can help patients with painful diabetic neuropathy. |
| NCT00062673 ↗ | Study of Duloxetine in Elderly Patients With Major Depressive Disorder | Completed | Eli Lilly and Company | Phase 3 | 2003-03-01 | A study of the safety and efficacy of duloxetine in elderly patients (greater than 65 years old) with major depressive disorder |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for duloxetine hydrochloride
Condition Name
Clinical Trial Locations for duloxetine hydrochloride
Trials by Country
Clinical Trial Progress for duloxetine hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for duloxetine hydrochloride
Sponsor Name
